Mediclinic International Ltd Value Stock - Dividend - Research Selection
Market price: 2,94 GBP
Mediclinic International Ltd. Fundamental data and company key figures of the share
|Annual reports in GBP|
|Net operating cash flow||456.000.000|
|Free cash flow||264.000.000|
|Liabilities & Shareholders equity||6.954.000.000|
|Diluted shares outstanding||737.327.000|
✓ NEW Fundamental API Access to 500 data points per month
✓ Fundamental data up to 25 years
✓ Comparison to all other stocks by the FScore
✓ Time saving!
How our site works ...
✓ Non-binding 7 days without automatic subscription
✓ No termination required after the free week
✓ Finanzoo fundamental analysis
✓ Data updated daily
✓ Virtual depots
✓ Share alarms via email
✓ Subscription can be canceled at any time at the end of the month
✓ Choice of desired shares
✓ Over 2000 stock analyzes available
✓ Bitcoin payment possible if you do not want to subscribe
Price for monthly subscription $ 19.99 / month including VAT.
|Market Capitalization||2.756.725.504,00 USD|
|Raw Data Source||IFRS in Millionen GBP|
|Stock Split||2017-12-04,108.0000/100.0000; 2016-12-20,105.0000/100.0000; 2005-01-11,130.0000/100.0000; 2004-03-04,11.0000/10.0000; 2003-05-08,11.0000/10.0000; 2001-12-13,110.0000/100.0000; 2001-02-01,11.0000/10.0000|
Description of the company
Mediclinic International, founded in 1983, is an international private hospital group with operations in South Africa, Namibia, Switzerland and the United Arab Emirates, and listed on the JSE, the South African securities exchange, since 1986. The Company has a secondary listing on the Namibian Stock Exchange since December 2014. The Group’s head office is based in Stellenbosch, South Africa.
To be respected internationally and preferred locally.
WHAT WE DO
Mediclinic is a private hospital group focused on providing acute care, specialist-orientated, multidisciplinary healthcare services. We place science at the heart of our care process by providing evidence-based care of the highest standard. Our patients receive controlled and customised treatment, orchestrated by a team of world-class specialists devoted to delivering the best possible clinical outcomes in multi-disciplinary facilities that are of a world-class standard. Our core purpose is to enhance the quality of life of our patients by providing comprehensive, high-quality healthcare services in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, doctors and funders of healthcare.